Executive Summary
Summary Anchiano Therapeutics Ltd (Anchiano) formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's product pipeline candidates is being evaluated for the treatment of bladder cancer, ovarian cancer and pancreatic cancer. The company develops its products based on its proprietary, personalized cancer therapy approach H19, which plays a key role in the development, progress, drug resistance and metastasis of most human cancers. Anchiano is headquartered at Jerusalem, Israel. Anchiano Therapeutics Ltd (BICL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. - Business Description-A brief description of the company's operations. - Key Employees-A list of the key executives of the company. - Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors-A list of the key competitors of the company. - Key Recent Developments-A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Read More
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 Anchiano Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 9 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 11 Equity Offering 11 Anchiano Therapeutics (BioCancell) Files Draft Registration Statement for Public Offering 11 BioCancell Raises USD23 Million in Private Placement of Shares 12 BioCanCell to Raise up to USD25 Million in Private Placement of shares 13 Biocancell Therapeutics to Raise USD6 Million in Private Placement of Shares 14 BioCancell Therapeutics Announces Rights Offering Of Shares For USD 2.6 Million 15 BioCancell Therapeutics Completes Public Offering Of Shares For USD 4.75 Million 16 BioCancell Therapeutics Announces Public Offering Of Shares For USD 4 Million 17 Anchiano Therapeutics Ltd-Key Competitors 18 Anchiano Therapeutics Ltd-Key Employees 19 Anchiano Therapeutics Ltd-Locations And Subsidiaries 20 Head Office 20 Other Locations & Subsidiaries 20 Recent Developments 21 Financial Announcements 21 Aug 22, 2018: BioCanCell announces second quarter 2018 financial results 21 Corporate Communications 22 Aug 30, 2018: Anchiano Therapeutics appoints Efrat Makov to its board of directors 22 Mar 07, 2018: BioCanCell Announces Two New Hires in Clinical Development and Clinical Operations 23 Aug 14, 2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors 24 Clinical Trials 25 Nov 15, 2017: BioCanCell Announces Updated Results from the Phase 2 Clinical Trial of BC-819 and BCG in Patients with Bladder Cancer 25 Other Significant Developments 26 Aug 27, 2018: BioCanCell announces company name change to Anchiano Therapeutics 26 Appendix 27 Methodology 27 About GlobalData 27 Contact Us 27 Disclaimer 27
List of Tables Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Anchiano Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8 Anchiano Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 9 Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Anchiano Therapeutics (BioCancell) Files Draft Registration Statement for Public Offering 11 BioCancell Raises USD23 Million in Private Placement of Shares 12 BioCanCell to Raise up to USD25 Million in Private Placement of shares 13 Biocancell Therapeutics to Raise USD6 Million in Private Placement of Shares 14 BioCancell Therapeutics Announces Rights Offering Of Shares For USD 2.6 Million 15 BioCancell Therapeutics Completes Public Offering Of Shares For USD 4.75 Million 16 BioCancell Therapeutics Announces Public Offering Of Shares For USD 4 Million 17 Anchiano Therapeutics Ltd, Key Competitors 18 Anchiano Therapeutics Ltd, Key Employees 19 Anchiano Therapeutics Ltd, Other Locations 20 Anchiano Therapeutics Ltd, Subsidiaries 20
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Anchiano Therapeutics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
|
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
